Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
erythrasma
MeSH D004894 - erythrasma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D017192:
Bacterial skin diseases
151 Companies
64 Drugs
$
Success rate
D003354:
Corynebacterium infections
0 Companies
0 Drugs
Success rate
D004894:
Erythrasma
54 Companies
6 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Erythromycin
,
Erythromycin lactobionate
Mylan
Erythromycin
,
Erythromycin estolate
,
Erythromycin gluceptate
,
Erythromycin lactobionate
,
Erythromycin stearate
Johnson & Johnson
Erythromycin
,
Erythromycin estolate
,
Erythromycin gluceptate
,
Erythromycin lactobionate
,
Erythromycin stearate
Bausch Health Companies
Benzoyl peroxide
,
Erythromycin
,
Erythromycin estolate
,
Erythromycin gluceptate
,
Erythromycin lactobionate
,
Erythromycin stearate
Pfizer
Erythromycin
,
Erythromycin estolate
,
Erythromycin gluceptate
,
Erythromycin lactobionate
,
Erythromycin stearate
Eli Lilly
Erythromycin
,
Erythromycin lactobionate
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use